ImmunityBio (IBRX) Soars 11% as Asian Expansion Looms

ImmunityBio Inc. (NASDAQ:IBRX) is one of the 10 Stocks to Watch Today.

ImmunityBio jumped by 10.98 percent on Monday to close at $9.40 apiece, as investors cheered its future expansion into Asia following the go-signal of the Macau special administrative region (SAR) for its bladder cancer treatment, Anktiva.

In a statement over the weekend, ImmunityBio Inc. (NASDAQ:IBRX) said that it officially secured the green light of Macau to market and sell Anktiva in the SAR, marking its first entry into Asia.

“This authorization marks an important step in establishing ANKTIVA in Asia and advancing our broader international expansion strategy,” ImmunityBio Inc. (NASDAQ:IBRX) President and CEO Richard Adcock said.

ImmunityBio (IBRX) Soars 11% as Asian Expansion Looms

“We are engaging with additional health authorities across the Asia-Pacific region and, in parallel, beginning to prepare for potential commercial distribution, recognizing there is still meaningful work ahead as we pursue further regulatory authorizations. Our focus is on executing this expansion in a disciplined manner, building on our existing approvals to support long-term global access for patients,” he noted.

The recent approval followed earlier permissions from the United States, Europe, and Saudi Arabia to market and sell the same treatment in the said areas.

Last year, Anktiva propelled ImmunityBio Inc.’s (NASDAQ:IBRX) full-year 2025 revenues by 671 percent to $113 million from only $14.7 million in 2024, reflecting strong adoption for the treatment, with sales volume expanding by 750 percent.

While we acknowledge the risk and potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IBRX and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.